ABSTRACT
Objective To designe, synthesize a series of chlorin p6 ether photosensitizers and preliminarily investigate their photodynamic antitumor activity based on previous research results that alkoxyl ether derivatives of 3-vinyl on chlorin f exhibited stronger photosensitive antitumor activity than parent compound. Methods Purpurin-18 (4) was obtained by oxidative degradation with air and alkali on pheophorbide a (5) which was prepared through acid hydrolysis of chlorophyll a from crude chlorophyll extracts in Chinese traditional herb named Silkworm excrement. Then, chlorin p6 trimethylester (2) were formed via basic hydrolysis of internal anhydride ring for lead compound 3 and following immediately methylation with CH2N2. The intermediate 2 reacted with 33% HBr, following nucleophilic substitution with various alkoxyl alcohol to get six title compounds (1). All title compounds were subjected to photodynamic antitumor activity screening for melanoma B16-F10 cell in vitro. Results All title compounds showed much higher phototoxicity against melanoma B16-F10 cells than talaporfin and verteporfin. Their structures were confirmed by 1H-NMR, 13C-NMR, ESI-MS and ESI-HRMS spectra. Conclusion Chlorin p6 ether compounds were promising candidate photosensitizers for PDT applications due to theirs high dark toxicity/phototoxicity ratio and excellent phototoxicity, which were worthy of further research and development.
ABSTRACT
Theodore maiman in 1960 invented the ruby laser, since then lasers technology has holded the attention in dental practice and has revolutionised dental treatment. Lasers have been used in initial periodontal therapy, surgery, and also in implant treatment. Lasers have various periodontal applications including calculus removal; for removal of the pocket epithelium; soft tissue excision, incision and ablation; decontamination of root and implant surfaces; biostimulation; bacteria reduction; and osseous surgery. Further research is necessary on lasers so that it can become a part of the dental procedures. This paper gives an acuity to laser in Periodontics.
ABSTRACT
Con base en trabajos de carácter cualitativo y con enfoque de investigación acción participación IAP, se diseñó y se pusieron en funcionamiento varias obras arquitectónicas en Manizales, Marquetalia, Pácora, Pensilvania, Samaná y Chinchiná (Caldas), no solo de beneficio urbanístico, sino ambiental y social. Se logró que las comunidades se involucraran y participaran de manera integral a través de sus familias, lo cual garantizó la pertenencia y el cuidado posterior, logrando a su vez, muy buenas relaciones entre ellos y las diferentes entidades que apoyaron el proyecto.
Several architectural constructions, based on work of a qualitative nature and applying an action research approach IAP, were designed and put into operation in Manizales, Marquetalia, Pácora, Pensilvania, Samaná and Chinchiná (Caldas) not only for the urban benefit, but also for the environmental and social benefit. It was possible for communities to become involved and participate in a comprehensive manner through their families which guaranteed the sense of belonging and the subsequent care, achieving in turn very good relations between the community and the different entities that supported the project.
Subject(s)
Community Participation , Conservation of Natural ResourcesABSTRACT
Objective To investigate the efficacy and safety of ALA-PDT combined with Quxietang douc-hing in the treatment of cervical HPV infection.Methods 208 female cervical PCR-HPV positive patients were randomly divided into treatment group and control group,each group had 104 cases.The control group received 10%(ALA)in cervical for 3 hours,then red light for 30 minutes once a week,a total of 3 times.Treatment group was given 10% (ALA)in cervical for 3 hours,then red light for 30 minutes once a week,a total of 3 times,and douching vagina with Quxietang,one day at a time,stay 3 weeks.After treatment for 3 months,every month,a cervical PCR-HPV check was conducted,summarized virus removal efficiency.Results The virus removal efficiency of treatment group was 89.42%,that of the control group was 73.08%,the difference was statistically significant (χ2 =7.471,P<0.05 ).The patients in the treatment group had light local mild erythema,swelling,burning pain,without treatment subside.Conclusion ALA -PDT combined with Quxietang douching method is efficient,with mild adverse reactions,the treatment group was better than the control group in removing cervical HPV infection and effectively eliminating the hidden trouble of cervical HPV.
ABSTRACT
O trabalho in vitro avaliou a eficácia da inativação fotodinâmica (PDI) da eritrosina (E) e hematoporfirina IX (H), com 10 µM, utilizando LED azul, dose de 75 J/cm2 em células planctônicas e biofilme de S. mutans (UA 159). Suspensões padrões contendo107 células/mL foram preparadas e submetidas a diferentes condições experimentais: a) hematoporfirina IX e LED (H+L+); b) eritrosina eLED (E+L+); c) apenas LED (F-L+); d) tratamento somente com hematoporfirina IX (H+L-); e) somente com eritrosina (E+L-); e f) grupo controle, sem tratamento com fotossensibilizador (F) e sem a utilização de LED (F-L-). As cepas foram semeadas em ágar MSBS para contagem de unidades formadoras de colônias (UFC/mL). Na segunda parte do trabalho foi realizado a PDI em biofilme de S.mutans sobre bráquetes metálicos e cerâmicos, com H a 10 µM e LED azul. Os resultados foram submetidos à análise de variância e teste de Tukey (p<0,05) e demonstraram que a E sob efeito do LED(E+L+) não foi eficaz na PDI de células planctônicas, nos parâmetros usados (p=0,3644). No entanto, a H promoveu redução de 6,78 log10(p<0,0001), no grupo de tratamento (H+L+). A PDI com a associação da H e LED foi efetiva na redução de 100% de culturas planctônicas de S. mutans, porém o mesmo não foi observado na associação com a E, na dosimetria utilizada no experimento. A PDI no biofilme de S. mutans sobre bráquetes metálicos, com a H e LED não foi eficaz nos parâmetros utilizados (p=0,1023), no entanto, ocorreu diminuição significativa de 53% sobre bráquetes cerâmicos (p=0,004). A H IX modificada é promissora como agente fotossensibilizador a ser empregado na técnica de PDI em associação ao LED azul, sendo necessários outros ensaios, em novas concentrações e/ou dosimetrias para se conseguir a inativação bacteriana.
The in vitro study evaluated the efficacy of photodynamic inactivation(PDI) with erythrosine (E) and hematoporphyrin (H) 10 µM, using ablue light-emitting diode (LED), a fluence of 75 J/cm2, on planktoniccultures and biofilm of S. mutans (UA 159). Suspensions containing107 cells/mL were prepared and were tested under differentexperimental conditions: a) hematoporphyrin IX and LED (H+L+); b)erythrosine and LED irradiation (E+L+); c) only LED (P-L+); d)only hematoporphyrin IX (H+L-); e) only erythrosine (E+L-); and f)control group, no LED irradiation or photosensitizer (P) treatment(P-L-). After treatment, the strains were seeded onto MSBS agar inorder to determine the number of colony-forming units (CFU/mL).The second part of this work consisted of the PDI of S. mutans biofilmon metal and ceramic brackets with the H 10 μM and blue LED. Theresults were submitted to analysis of variance and the Tukey test(p<0.05) and showed that E under the effect of LED proved to beineffective in the PDI of planktonic cultures with the parameters used(p=0.3644). H, however, caused a reduction of 6.78 log10 (p<0.0001)in the treatment group (H+L+). PDI with H and LED exertedantimicrobial effect of 100% of the S. mutans strain studied, whereasthe same was not observed in the association with E in the dosimetryused in this work. PDI on S. mutans biofilm on metal brackets, with Hand LED was not effective with the parameters used (p=0.1023), however on ceramic brackets caused a significant reduction of 53%(p=0,004). Modified H IX is a promising photosensitizer to be used inthe PDI technique in combination with blue LED. Therefore, new testswith new concentrations and/or dosimetry are needed to achievebacterial inactivation.
Subject(s)
Biofilms , Dental Caries , Erythrosine , In Vitro Techniques , OrthodonticsABSTRACT
O trabalho in vitro avaliou a eficácia da inativação fotodinâmica (PDI) da eritrosina (E) e hematoporfirina IX (H), com 10 µM, utilizando LED azul, dose de 75 J/cm2 em células planctônicas e biofilme de S. mutans (UA 159). Suspensões padrões contendo107 células/mL foram preparadas e submetidas a diferentes condições experimentais: a) hematoporfirina IX e LED (H+L+); b) eritrosina eLED (E+L+); c) apenas LED (F-L+); d) tratamento somente com hematoporfirina IX (H+L-); e) somente com eritrosina (E+L-); e f) grupo controle, sem tratamento com fotossensibilizador (F) e sem a utilização de LED (F-L-). As cepas foram semeadas em ágar MSBS para contagem de unidades formadoras de colônias (UFC/mL). Na segunda parte do trabalho foi realizado a PDI em biofilme de S.mutans sobre bráquetes metálicos e cerâmicos, com H a 10 µM e LED azul. Os resultados foram submetidos à análise de variância e teste de Tukey (p<0,05) e demonstraram que a E sob efeito do LED(E+L+) não foi eficaz na PDI de células planctônicas, nos parâmetros usados (p=0,3644). No entanto, a H promoveu redução de 6,78 log10(p<0,0001), no grupo de tratamento (H+L+). A PDI com a associação da H e LED foi efetiva na redução de 100% de culturas planctônicas de S. mutans, porém o mesmo não foi observado na associação com a E, na dosimetria utilizada no experimento. A PDI no biofilme de S. mutans sobre bráquetes metálicos, com a H e LED não foi eficaz nos parâmetros utilizados (p=0,1023), no entanto, ocorreu diminuição significativa de 53% sobre bráquetes cerâmicos (p=0,004). A H IX modificada é promissora como agente fotossensibilizador a ser empregado na técnica de PDI em associação ao LED azul, sendo necessários outros ensaios, em novas concentrações e/ou dosimetrias para se conseguir a inativação bacteriana
The in vitro study evaluated the efficacy of photodynamic inactivation(PDI) with erythrosine (E) and hematoporphyrin (H) 10 µM, using ablue light-emitting diode (LED), a fluence of 75 J/cm2, on planktoniccultures and biofilm of S. mutans (UA 159). Suspensions containing107 cells/mL were prepared and were tested under differentexperimental conditions: a) hematoporphyrin IX and LED (H+L+); b)erythrosine and LED irradiation (E+L+); c) only LED (P-L+); d)only hematoporphyrin IX (H+L-); e) only erythrosine (E+L-); and f)control group, no LED irradiation or photosensitizer (P) treatment(P-L-). After treatment, the strains were seeded onto MSBS agar inorder to determine the number of colony-forming units (CFU/mL).The second part of this work consisted of the PDI of S. mutans biofilmon metal and ceramic brackets with the H 10 μM and blue LED. Theresults were submitted to analysis of variance and the Tukey test(p<0.05) and showed that E under the effect of LED proved to beineffective in the PDI of planktonic cultures with the parameters used(p=0.3644). H, however, caused a reduction of 6.78 log10 (p<0.0001)in the treatment group (H+L+). PDI with H and LED exertedantimicrobial effect of 100% of the S. mutans strain studied, whereasthe same was not observed in the association with E in the dosimetryused in this work. PDI on S. mutans biofilm on metal brackets, with Hand LED was not effective with the parameters used (p=0.1023), however on ceramic brackets caused a significant reduction of 53%(p=0,004). Modified H IX is a promising photosensitizer to be used inthe PDI technique in combination with blue LED. Therefore, new testswith new concentrations and/or dosimetry are needed to achievebacterial inactivation
Subject(s)
Biofilms , Dental Caries , Erythrosine , In Vitro Techniques , OrthodonticsABSTRACT
PURPOSE: The aim of this study was to investigate whether the peroxisomal proliferator-activated receptor gamma (PPARγ) ligand troglitazone in combination with photodynamic therapy (PDT) enhances the apoptotic response of DLD-1 colon cancer cells. MATERIALS AND METHODS: The effects of troglitazone, PDT, and troglitazone in combination with PDT on cell viability and apoptosis were assessed in DLD-1 cells. Cell viability and proliferation were evaluated using the tetrazolium-based MTT assay, and apoptosis was evaluated via cell staining with propidium iodide (PI) and annexin V-FITC. The levels of pro-caspase-3 were measured via Western blot analyses. RESULTS: Treatment of troglitazone and PDT induced the growth retardation and cell death of DLD-1 cells in a dose-dependent manner, respectively. The combination treatment significantly suppressed cell growth and increased the apoptotic response of DLD-1 and resulted in apoptosis rather than necrosis, as shown by PI/annexin V staining and degradation of procaspase-3. CONCLUSION: Conclusion: These results document the anti-proliferative and apoptotic activities of PDT in combination with the PPARγ ligand troglitazone and provide a strong rationale for testing the therapeutic potential of combination treatment in colon cancer.
Subject(s)
Apoptosis , Blotting, Western , Caspase 3 , Cell Death , Cell Survival , Colon , Colonic Neoplasms , Necrosis , Photochemotherapy , PropidiumABSTRACT
PURPOSE: The aim of this study was to investigate whether the peroxisomal proliferator-activated receptor gamma (PPARγ) ligand troglitazone in combination with photodynamic therapy (PDT) enhances the apoptotic response of DLD-1 colon cancer cells. MATERIALS AND METHODS: The effects of troglitazone, PDT, and troglitazone in combination with PDT on cell viability and apoptosis were assessed in DLD-1 cells. Cell viability and proliferation were evaluated using the tetrazolium-based MTT assay, and apoptosis was evaluated via cell staining with propidium iodide (PI) and annexin V-FITC. The levels of pro-caspase-3 were measured via Western blot analyses. RESULTS: Treatment of troglitazone and PDT induced the growth retardation and cell death of DLD-1 cells in a dose-dependent manner, respectively. The combination treatment significantly suppressed cell growth and increased the apoptotic response of DLD-1 and resulted in apoptosis rather than necrosis, as shown by PI/annexin V staining and degradation of procaspase-3. CONCLUSION: Conclusion: These results document the anti-proliferative and apoptotic activities of PDT in combination with the PPARγ ligand troglitazone and provide a strong rationale for testing the therapeutic potential of combination treatment in colon cancer.
Subject(s)
Apoptosis , Blotting, Western , Caspase 3 , Cell Death , Cell Survival , Colon , Colonic Neoplasms , Necrosis , Photochemotherapy , PropidiumABSTRACT
AIM: To observe the curative effect of PDT combined with intravitreal injection of ranibizumab treatment for age-related macular degeneration with choroidal neovascularization ( CNV) . METHODS:In accordance with the inclusion criteria, by indocyanine green choroidalangiography ( ICGA ) and optical coherence tomography ( OCT ) examination confirmed the diagnosis of macular CNV in 27 patients (27 eyes), treated with PDT 3 ~ 7d professional intravitreal injection of ranibizumab. At 1, 3, 6mo after treatment, the results of best corrected visual acuity (BCVA), FFA, ICGA, OCT examination and complications were observed. RESULTS: The BCVA improved in 17 eyes ( 63%) , stable in 6 eyes ( 22%) , and decreased in 4 eyes ( 15%) . Before treatment, the average leakage area was 1 005. 69±105. 47μm, it were 875. 54 ± 103. 27μm, and 423. 37 ±79.68μm at 1 and 3mo after treatment, there were significant differences compared with before treatment ( PCONCLUSION: The method that PDT closed CNV combined with intravitreal injection of ranibizumab can effectively block angiogenesis recurrence, reduce the number of PDT treatment again and complications, improve the therapeutic effect.
ABSTRACT
Objective To compare the manipulation of two different methods of percutaneous dilatational tracheostomy (PDT),the guidewire dilating forceps (Portex method) and the modified onestep dilation technique (Ciaglia Blue Rhino method,CBR method).Methods From March 2013 to February 2014,48 patients eligible to meet the criteria of tracheostomy in ICU were collected and were divided into two groups at random.The length of time consumed for operation,amount of blood lost during operation and the operation complications were compared between two groups.The participant surgeons were asked which method they preferred,Portex or CBR.Results Of them,the mean age was 76.7 ± 11.6 years old,and 25 patients (52.1％) were male.The reasons for tracheotomy were the length of time needed for mechanical ventilation support expected to be longer than 2 weeks (n =30),severe disturbance of consciousness (n =17),and upper airway obstruction (n =1).The patients enrolled in the study were randomly divided into Portex and CBR groups.There were no significant differences in age,gender,APACHE Ⅱ score,the reason of tracheotomy,the length of time for mechanical ventilation support before tracheotomy,and the preoperative coagulation function between two groups.CBR method can easily be done with less operation time required than Portex [(5.9 ±4.3) min vs.(9.9 ± 1.5) min,P ＜0.01],and had obviously fewer operation complications and less amount of blood lost than Portex method (P ＜ 0.05).The male surgeons with a slew of surgical practice were in preference to Portex,whereas female doctors with less work experience and without surgical practice preferred CBR.Conclusions The CBR method can easier be done and was better than the Portex method in minimizing operative trauma and reducing the complications,especially it can easily be accepted by female doctors with less work experience and without surgical practice and it is worth using widely in clinic.
ABSTRACT
Objective:To observe the clinical effects of dexmedetomidine(DDM)under monitored anesthesia care(MAC)in oral and maxillofacial patients undergoing percutaneous dilatational tracheostomy(PDT).Methods:38 patients with oral and maxillofa-cial tumor undergoing PDT before surgery were randomly assigned into 2 groups(n =19).Patients in group D received a single-dose DDMof 0.5 μg/kg infused for 10 min;those in group Mreceived 2 mg of midazolam and 1 μg/kg of fentanil.Then all patients were given local anesthesia followed by PDT.MAP,HR and SpO2 were monitored before (T0 )and after drug administration (T1 ),at T2 (skin incision)and T3 (insert dilation catheter).Ramsay scorce,bucking,respiration depression and adverse cardiovascular reaction were recorded.All patients were followed up 24 h postoperatively for the observation of adverse recall of PDT.Results:Compared with T0 ,at T1 ,T2 MAP and HR in group D were lower,but MAP and HR at T3 in group Mwere higher(P <0.05).At T1 ,T2 and T3 ,MAP and HR in group D were significantly lower than those in group M(P <0.05).During operation,the incidence of bucking and respiration depression in group D was lower than that in group M(P <0.05).Conclusion:During PDT operation under MAC,a single-dose dexmedetomidine is effective in stablizing hemodynamics,reducing bucking and respiration depression.
ABSTRACT
Photodynamic therapy (PDT), also known as photo-radiation therapy, phototherapy, or photo-chemotherapy, involves the use of a photoactive dye (photosensitizer) that is activated by exposure to light of a specific wavelength in the presence of oxygen. The transfer of energy from the activated photosensitizer to available oxygen results in the formation of toxic oxygen species, such as singlet oxygen and free radicals which damages proteins, lipids, nucleic acids and other cellular components.PDT has wide range of applications in Dentistry ranging from antimicrobial chemotherapy to the diagnosis & treatment of premalignant and malignant conditions. Its application in Periodontics represents a novel therapeutic approach in the management of oral biofilms with consequent alterations in plaque homeostasis. An improved post surgical healing with reduced periodontal inflammation and tissue damage are the hallmarks of PDT. Its scope has been extended in Implantology to promote osseointegration and to prevent peri-implantitis. With such myriad of applications PDT has a promising future depending on the interactions between clinical applications and technological innovations. The paper appraises the various scopes that PDT envisages beyond the horizon.
ABSTRACT
Sixteen cases of malignant soft tissue sarcoma (STS; 10 canines and six felines) were treated with a novel triple therapy that combined photodynamic therapy, hyperthermia using indocyanine green with a broadband light source, and local chemotherapy after surgical tumor resection. This triple therapy was called photodynamic hyperthermal chemotherapy (PHCT). In all cases, the surgical margin was insufficient. In one feline case, PHCT was performed without surgical resection. PHCT was performed over an interval of 1 to 2 weeks and was repeated three to 21 times. No severe side effects, including severe skin burns, necrosis, or skin suture rupture, were observed in any of the animals. No disease recurrence was observed in seven out of 10 (70.0%) dogs and three out of six (50.0%) cats over the follow-up periods ranging from 238 to 1901 days. These results suggest that PHCT decreases the risk of STS recurrence. PHCT should therefore be considered an adjuvant therapy for treating companion animals with STS in veterinary medicine.
Subject(s)
Animals , Cats , Dogs , Antineoplastic Agents/therapeutic use , Cat Diseases/drug therapy , Combined Modality Therapy/veterinary , Dog Diseases/drug therapy , Hyperthermia, Induced/veterinary , Indocyanine Green/therapeutic use , Photochemotherapy/veterinary , Photosensitizing Agents/therapeutic use , Sarcoma/drug therapyABSTRACT
[Objective] To observe the cure effect of photodynamic therapy(PDT) combined with TCM on verruca acuminata. [Method] Select 80 cases of verruca acuminata, divide them into control group and treatment group, n=40 for each; the control one only took LE D-IB PDT therapeutic apparatus, the treatment one added with TCM on the base of control one; Observe their cure effects and side effects. [Result] The effective rate was 97.5% for treatment group, and 88.5% for control one, the treatment one was better than other one; there ’re 2 cases in each group respectively who had slight red and swol en skin of the il umination part, without side effects of erosion, ulcer, infection or scar;the recurrence rates were respectively 2.5% and 12.5% for both groups, the difference had statistical meaning. [Conclusion] PDT combined with TCM treating verruca acuminata had high cure rate, low recurrence rate, little side effects and high safety, without influencing patients ’life quality, with good compliance, worth clinical broad popularization.
ABSTRACT
Nanoparticles of fullerenes and their water-soluble derivatives have been firmly introduced into solution of medical problems. Although there are still debates about their toxicity and long-term consequences of their application in the clinic, the success of fullerenes application in some sections is undeniable, in particular, in photodynamic therapy (PDT) of cancer tumors. Besides there are interesting data on radiotherapy where fullerenes appear to be more transporters than drugs, but due to own cytoprotective properties, the fullerene adducts can also participate in the combined treatment. This review evaluates the status of these sections of fullerene chemistry in terms of development and recent trends.
ABSTRACT
PURPOSE: To determine predictive factors associated with visual outcome after treatment for myopic choroidal neovascularization (mCNV). METHODS: Medical records of the patients who underwent photodynamic therapy (PDT), intravitreal anti-vascular endothelial growth factor (Anti-VEGF) injection, or combination therapy of PDT and Anti-VEGF for myopic CNV, and followed up for more than a year, were reviewed retrospectively. Multiple linear regression analyses were performed to evaluate the predictive factors significantly associated with the visual outcome at 1 year after the treatment. RESULTS: Mean best-corrected visual acuity (BCVA) of 45 eyes of 45 patients showed statistically significant improvement 1 year after the treatment with a mean of 3.5 line improvement (p < 0.01, Wilcoxon signed rank test). Age, 1-month BCVA after treatment and treatment type appeared to be associated with the 1-year visual outcome after treatment for mCNV (p = 0.033, p < 0.001, and p = 0.044, respectively, multivariate linear regression analysis). CONCLUSIONS: Younger age (less than 40 years), better 1-month BCVA after treatment, intravitreal Anti-VEGF monotherapy were associated with improved visual outcome after treatment for mCNV. In particular, 1-month BCVA after treatment is a useful indicator to predict therapeutic response after treatment for mCNV.
Subject(s)
Humans , Antibodies, Monoclonal, Humanized , Choroid , Choroidal Neovascularization , Endothelial Growth Factors , Eye , Linear Models , Medical Records , Photochemotherapy , Retrospective Studies , Triazenes , Visual Acuity , Bevacizumab , RanibizumabABSTRACT
PURPOSE: To analyze the long-term results of photodynamic therapy (PDT) for exudative age-related macular degeneration (AMD). METHODS: The clinical data of patients treated with photodynamic therapy for exudative age-related macular degeneration between April 2000 and December 2000 were analyzed. Patients were followed-up for at least 10 years after PDT. RESULTS: Twenty-nine eyes of 29 patients were enrolled. Mean visual acuity on the logarithm of the minimum angle of resolution (log MAR) scale was 0.78 +/- 0.34 at baseline, 1.01 +/- 0.42 at 60 months, and 1.02 +/- 0.41 at 120 months. Predominantly classic, minimally classic, and occult without classic choroidal neovascularization was noted in 51.7%, 17.2%, and 31.1% of patients, respectively. Visual acuity was improved by 1 or more lines in 27.6% of patients and was unchanged in 20.7% of patients, while 51.7% of patients had lost 1 or more lines of visual acuity by 120 months. Baseline visual acuity and age were associated with the final visual prognosis (p < 0.05). Four patients developed neovascular AMD in the contralateral eye. CONCLUSIONS: PDT is safe and effective for neovascular AMD. However, AMD can recur at any time and thus patients should be followed-up for a long period of time.
Subject(s)
Humans , Choroid , Choroidal Neovascularization , Eye , Macular Degeneration , Photochemotherapy , Prognosis , Triazenes , Visual AcuityABSTRACT
Objective To explore photodynamic therapeutic efficiency and related mechanisms of a new porphyrin-typed photodynamic therapy (PDT) drug synthesized in our lab on HGC27 and MGC803 cells.Methods Two different kinds of gastric cancer cells, HGC27 and MGC803, were chosen as cell lines to evaluate the PDT efficiency of new porphyrin-typed PDT drug based upon four group experiments: control (no drug, no light) group, drug treated group (only drug, no light), light treated group (no drug, only light) and experiment group (with drug and light at the same time). Bleaching method was used to evaluate the photostability of new porphyrin-typed PDT drug upon repititive illumination. MTT assay was carried out to test the survival rate of tumor cells after PDT. Cofocal laser scanning microscope (CLSM) was applied to observe subcellular localization of drug in HGC27 and MGC803 cells (mitochondria and lysosome). Results New porphyrin-typed PDT drug has good stability to light, no toxicity on HGC27 and MGC803 cells without light (P>0.05), while intense lethal effect was observed upon light illumination (P<0.05). The peak efficacy appeared when concentration is 3.12 μmol/L for both HGC27 and MGC803 cells and the new porphyrin-typed PDT drug localizes in lysosome other than traditional mitochondrion. Conclusion New porphyrin-typed PDT drug is a good photodynamic therapeutic sensitizer for HGC27 and MGC803 tumor cells.
ABSTRACT
PURPOSE: To presents the effect of triple therapy including C3F8 gas injection, intravitreal anti-VEGF injection and photodynamic therapy on patients with subretinal hemorrhage accompanied by choroidal neovascularization. METHODS: Twelve eyes of 12 patients suffering from subretinal hemorrhage accompanied by choroidal neovascularization with onset of the symptom within a week prior to three-day prone positioning after C3F8 gas injection were included in the present study. Next, intravitreal anti-VEGF injection and photodynamic therapy was performed. Then, within two months, intravitreal bevacizumab or ranibizumab injection was performed. RESULTS: After stabilization of the submacular hemorrhagic lesion, ten eyes of ten patients showed improved visual acuity, one eye showed no improvement, and decreased visual acuity developed in one patient. LogMAR visual acuity improved after the initial treatment from 1.05 +/- 0.43 to 0.74 +/- 0.58 and 0.53 +/- 0.51 at three and six months, respectively. The improvement was considered to be clinically significant. CONCLUSIONS: An appropriate regimen for treating broad submacular hemorrhage accompanied by choroidal neovascularization has not been established. The authors of the patients had obtained positive results from C3F8 gas injection, intravitreal anti-VEGF injection and photodynamic therapy. In the future, additional studies should be conducted.